PT. Penta Valent Tbk (IDX:PEVE)
314.00
-4.00 (-1.26%)
At close: Nov 5, 2026
PT. Penta Valent Tbk Revenue
PT. Penta Valent Tbk had revenue of 983.06B IDR in the quarter ending September 30, 2026, with 9.00% growth. This brings the company's total for the last twelve months to 3.78T, up 10.91% year-over-year. In the year 2025, PT. Penta Valent Tbk had annual revenue of 3.55T with 17.77% growth. That makes PT. Penta Valent Tbk the 17,185th largest company in the world by revenue and 234th in Indonesia.
Revenue (ttm)
3.78T
Revenue Growth
+10.91%
P/S Ratio
0.15
Revenue / Employee
2.51B
Employees
1,504
Market Cap
554.41B
Revenue by Segment
- Pharmaceutical Product 2.87T 80.9%
- Consumer Product 679.29B 19.1%
Fiscal year ended Dec 31, 2025 See the full PT. Penta Valent Tbk breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.55T | 535.25B | 17.77% |
| Dec 31, 2024 | 3.01T | 528.07B | 21.25% |
| Dec 31, 2023 | 2.48T | 337.34B | 15.71% |
| Dec 31, 2022 | 2.15T | 359.31B | 20.10% |
| Dec 31, 2021 | 1.79T | 407.33B | 29.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 38.31T |
| PT Siloam International Hospitals Tbk | 13.91T |
| PT Mitra Keluarga Karyasehat Tbk | 5.66T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.72T |
| PT Itama Ranoraya Tbk | 1.04T |
| PT Royal Prima Tbk | 320.78B |
| PT Diastika Biotekindo Tbk | 224.95B |
| PT Esa Medika Mandiri Tbk | 223.91B |